Permanent Hair Loss in Some Taxotere Users Delivers Secondary Blow to Cancer Patients

Chemotherapy drug side effects provide a daily reminder of cancer for some in the form of permanent hair loss

Monday, June 5, 2017 - There are certain times in life when we are the most vulnerable and being informed that you have cancer is without doubt one of them. Nearly everyone who is diagnosed with the disease is scared to death of the pain and suffering that they may have to endure, not only from the disease but also from the side effects of radiation or chemotherapy that is prescribed. Since cancer treatments are scientifically sophisticated and beyond the scope of knowledge of the common person, most of us place our full trust and confidence in the doctors we are referred to. We expect that the knowledge and experience that they have will be of benefit to us as we fight the disease. None of us think to question the prognosis or the recommended course of treatments that our cancer doctors, called oncologists, prescribe. None of us expect that a drug that the oncologist recommends that we take will have side effects that can physically and emotionally scar us for life, but that's exactly what has happened to hundreds of thousands, perhaps millions of Americans. Oncologists in America have prescribed a cancer treatment drug called Taxotere to their cancer patients which is causing permanent, irreversible baldness called "alopecia" in approximately 10-15 % of the patients who take the drug.

Taxotere is a prescription medication used in chemotherapy to combat breast and other cancers in women. Chemotherapy is the use of chemicals to fight any disease but has come to be associated with fighting cancers. Chemotherapy is often used in combination with radiation therapy. The difference is that radiation seeks to pinpoint a certain area of the body while chemotherapy migrates throughout the body through the bloodstream. Taxotere is intended to slow or stop the growth and spread of cancer cells and is highly toxic but not proven to be any more effective than other cancer fighting chemical therapies. In addition to breast cancer, the drug is currently used for lung, prostate, stomach and neck cancers. Side effects of the drug have been described as "injection site reactions (pain, redness, or swelling), nausea, vomiting, diarrhea, constipation, loss of appetite, feeling weak or tired, muscle pain, joint pain, missed menstrual periods, temporary hair loss, and fingernail or toenail changes." Nowhere is the mention of permanent hair loss.

If you have taken the cancer treatment drug Taxotere and experienced permanent hair loss you may be entitled to file a Taxotere hair loss lawsuit for damages and hold them accountable. Sinofil has been found to have fraudulently represented the drug by overstating its effectiveness in fighting cancer as well as covering up their advanced knowledge that the drug causes permanent baldness. As a result, the US Food and Drug Administration has issued warnings and stricter regulations on the company requiring them to inform consumers of the side effects. No one expects permanent hair loss to be a side effect of a cancer treatment drug and if you had known chances are you would have selected another equally as effective drug.

Permanent hair loss in men is one thing, but when women and young girls are faced with a life without hair, the psychological trauma can be particularly devastating. At the Onder Law Firm, it is our belief that the manufacturer of Taxotere, the French multinational pharmaceutical company Sanofi, had prior knowledge of this risk of permanent hair loss as a side effect from taking the drug, and not only willfully failed to disclose it, but also covered up their findings falsely claiming in their product literature that the resultant hair loss would be temporary.

More Recent Taxotere Hair Loss Lawsuit News:

• Taxotere Alopecia Warning Limited to the Fine Print | 5/17/2019
• Women that have to undergo chemotherapy for the first time face great anxiety | 5/6/2019
• Taxotere Patients Denied Their Right To Make An Informed Decision | 4/24/2019
• Patients Must Be Made Aware Of Taxotere's Three Major Side Effects | 4/18/2019
• Women Are Angry Over Sanofi Failing To Warn About The Possibility of Permanent Hair Loss | 4/12/2019
• Women Undergoing Cancer Treatments Are Taking Better Care of Themselves to Limit Hair Loss | 4/5/2019
• Taxotere Permanent Hair Loss Has Devastating Psychological Implications For Patients | 3/25/2019
• Taxotere Causes Alopecia Which Can Be Psychologically Damaging | 3/20/2019
• Drug Makers Need To Write Clearer, More Descriptive Drug Warnings Starting With Taxotere | 3/18/2019
• Taxotere Lawsuits May Teach Doctors a Valuable Lesson | 3/13/2019
• Taxotere Permanent Baldness Warning | 4/30/2018
• Taxotere Chemotherapy and Permanent Hair Loss | 4/26/2018
• Sanofi Sales Representatives Oversold Taxotere | 4/24/2018
• Scientific Study Confirms Permanent Taxotere Hair Loss | 4/12/2018
• Chemotherapy Drug Side Effects | 4/9/2018
• Cancer Doctors Fail to Warn Patients | 4/4/2018
• Taxotere's Psychological Side Effects | 3/13/2018
• Permanent Hair Loss Can Lead to Depression | 3/6/2018
• A Woman's Hair is Linked to Their Feminity | 2/23/2018
• Studies Indicate Taxotere Causes Permanent Hair Loss | 2/14/2018
• Taxotere's Ambiguous Hair Loss Warning | 2/5/2018
• Permanent Hair Loss Makes the Fear of Growing Old All Too Real | 12/29/2017
• Thousands of Women File Taxotere Hair Loss Lawsuits | 12/27/2017
• Taxotere Patients Psychological Trauma Result in Lawsuits Against Sanofi-Aventis | 12/22/2017
• Scientific Studies Point to Taxotere Hair Loss | 12/18/2017
• Cancer Patients Right to Make an Informed Decision | 12/13/2017
• How Women Think About Chemotherapy Hair Loss | 12/11/2017
• The Emotional Side Effects of Alopecia | 12/8/2017
• Taxotere May Cause Permanent Hair Loss | 12/4/2017
• Women Equate Baldness With Masculinity | 11/27/2017
• Symptoms of Permanent Hair Loss | 11/21/2017
• Taxotere's Warning May Have Come Too Late For Many | 11/15/2017
• Taxotere Benefits and Side Effects | 11/9/2017
• Women Were Not Given a Choice of Cancer Drugs | 11/1/2017
• The Impact of Permanent Hair Loss on Some Cancer Survivors | 9/29/2017
• The Emotional Side Effects of Permanent Hair Loss For Women Are All Too Real | 9/22/2017
• Taxotere is Highly Toxic and Causes Permanent Hair Loss | 9/15/2017
• 10-15 Percent of Cancer Patients Given Taxotere Develop Permanent Hair Loss | 9/8/2017
• Permanent Hair Loss From Taxotere is a Real Possibility | 9/1/2017
• Taxotere Permanent Hair Loss Lawsuits | 7/21/2017
• Permanent Hair Loss Caused by Taxotere | 6/26/2017
• Taxotere Warnings Now Include Permanent Hair Loss | 6/19/2017
• Taxotere Hair Loss Lawsuits Focus on Warning Label | 6/12/2017

Lawyers for Taxotere Hair Loss Lawsuits

Onder, Shelton, O'Leary & Peterson, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O'Leary & Peterson has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.